Tizanidine Hydrochloride Capsule
Product Images NDC 60760-892

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Tizanidine Hydrochloride (NDC 60760-892). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by St. Mary's Medical Park Pharmacy, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

892-30 (Tizanidine 60760 892 30)

This -recognized text appears to be a packaging label for Tizanidine, a medication commonly used to treat muscle spasms. The label includes details such as the drug's name, dosage (6mg capsules), quantity (30 capsules), lot number, expiration date, manufacturer (Ingenus Pharmaceuticals), and storage instructions. It is a prescription drug and must be used as directed. The text also indicates that the medication should be stored at controlled room temperature.*

FDA Label Image

Tizanidine Structure (Fe05ad15 Db11 4d9e 9fb8 721cec4633d9 01)

FDA Label Image

Figure 1 (Fe05ad15 Db11 4d9e 9fb8 721cec4633d9 02)

FDA Label Image

Figure 2 (Fe05ad15 Db11 4d9e 9fb8 721cec4633d9 03)

FDA Label Image

Figure 3 (Fe05ad15 Db11 4d9e 9fb8 721cec4633d9 04)

This text discusses the improvement in Ashworth Score after treatment with Tizanidine. The study involved titration and maintenance of a mean dose of 26.8 mg over a period of 7 weeks. The Ashworth Score is a measurement used in evaluating spasticity.*

FDA Label Image

Image (Fe05ad15 Db11 4d9e 9fb8 721cec4633d9 143 1)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.